Over time, many patients find that the combination of peptide therapy and overall wellness strategies creates lasting improvements in quality of life
Please consult your doctor and discuss all your queries related to any disease or medicine
F.DrynanL.FanJ.CurryA.FraserG.et al (2019)
The award funds research until December 31, 2021
Tirzepatide (22.5%) and Semaglutide (15%) are both FDA-approved and available today, with Tirzepatide showing superior results and better tolerability than Semaglutide
The following table breaks down key characteristics of various GLP-1 RAs, including Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, Saxenda, and Victoza, to give a clearer picture of their differences: This table elucidates the Ozempic vs Mounjaro debate, showing Mounjaros unique position with very high efficacy in both weight loss and blood sugar control